标题
The past, present, and future physiology and pharmacology of glucagon
作者
关键词
-
出版物
Cell Metabolism
Volume 34, Issue 11, Pages 1654-1674
出版商
Elsevier BV
发表日期
2022-11-01
DOI
10.1016/j.cmet.2022.10.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Heterogenous impairment of α cell function in type 2 diabetes is linked to cell maturation state
- (2022) Xiao-Qing Dai et al. Cell Metabolism
- More than meets the islet: aligning nutrient and paracrine inputs with hormone secretion in health and disease
- (2022) Taylor S. Morriseau et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Opposing roles of the entero-pancreatic hormone urocortin-3 in glucose metabolism in rats
- (2022) Kaare V. Grunddal et al. DIABETOLOGIA
- Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice
- (2022) Xiaona Cui et al. iScience
- Mechanisms controlling pancreatic islet cell function in insulin secretion
- (2021) Jonathan E. Campbell et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells
- (2021) K. El et al. Science Advances
- Dasiglucagon: A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia Results of Phase 3 Randomized Double-Blind Clinical Trial
- (2021) Thomas R. Pieber et al. DIABETES CARE
- The role of incretins on insulin function and glucose homeostasis
- (2021) Jens Juul Holst et al. ENDOCRINOLOGY
- Effects of endogenous GIP in patients with type 2 diabetes
- (2021) Signe Stensen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial
- (2021) Tadej Battelino et al. PEDIATRIC DIABETES
- Glucagon‐like peptide‐1 in diabetes care: Can glycaemic control be achieved without nausea and vomiting?
- (2021) Tito Borner et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
- (2021) Rajaa Nahra et al. DIABETES CARE
- Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats
- (2021) Emily G Hoffman et al. ENDOCRINOLOGY
- Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
- (2021) Julio Rosenstock et al. LANCET
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arginine vasopressin: Direct and indirect action on metabolism
- (2021) Mitsuhiro Yoshimura et al. PEPTIDES
- Pancreatic β Cells Inhibit Glucagon Secretion from α Cells: An In Vitro Demonstration of α–β Cell Interaction
- (2021) Wenqian Gu et al. Nutrients
- Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
- (2021) David C. D. Hope et al. Frontiers in Endocrinology
- Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
- (2021) Martin Bossart et al. Cell Metabolism
- Tirzepatide as an Insulin Sensitizer
- (2021) Ele Ferrannini JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
- (2021) Angela Kim et al. eLife
- Gq signaling in α cells is critical for maintaining euglycemia
- (2021) Liu Liu et al. JCI Insight
- Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects with Hepatic Steatosis
- (2020) Malte P. Suppli et al. DIABETES
- The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition
- (2020) Megan E. Capozzi et al. DIABETES
- GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals
- (2020) Lærke S Gasbjerg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- NASAL GLUCAGON DELIVERY IS MORE SUCCESSFUL THAN INJECTABLE DELIVERY: A SIMULATED SEVERE HYPOGLYCEMIA RESCUE
- (2020) Julie A. Settles et al. Endocrine Practice
- Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high fat diet
- (2020) Joely A. Kellard et al. Molecular Metabolism
- Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells
- (2020) Sarah M Gray et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Central nervous pathways of insulin action in the control of metabolism and food intake
- (2020) Stephanie Kullmann et al. Lancet Diabetes & Endocrinology
- Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study
- (2020) Jeffrey G. Suico et al. Diabetes Therapy
- Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets
- (2020) Berit Svendsen et al. DIABETOLOGIA
- Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia
- (2020) Nathalie Esser et al. DIABETOLOGIA
- Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
- (2020) Laurie L. Baggio et al. Molecular Metabolism
- Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
- (2020) Nadejda Bozadjieva Kramer et al. DIABETES
- The liver–alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels
- (2020) Christina Gar et al. DIABETOLOGIA
- Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis
- (2020) Marie Winther-Sørensen et al. Molecular Metabolism
- Branched-chain amino acids in disease
- (2019) Phillip J. White et al. SCIENCE
- The liver-alpha cell axis and type 2 diabetes
- (2019) Nicolai J Wewer Albrechtsen et al. ENDOCRINE REVIEWS
- Antisense Inhibition of Glucagon Receptor by IONIS-GCGRRx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy
- (2019) Erin S. Morgan et al. DIABETES CARE
- Postprandial Aminogenic Insulin and Glucagon Secretion can Stimulate Glucose Flux in Humans
- (2019) Teddy Ang et al. DIABETES
- Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
- (2019) Brian Finan et al. DIABETES
- The incretin system in healthy humans: The role of GIP and GLP-1
- (2019) Jens Juul Holst METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon Control on Food Intake and Energy Balance
- (2019) Omar Al-Massadi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Primary Role for Alpha Cells as Amino Acid Sensors
- (2019) E. Danielle Dean DIABETES
- Glucagon Regulation of Energy Expenditure
- (2019) Maximilian Kleinert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes
- (2018) Nicolai J. Wewer Albrechtsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point
- (2018) Rayner Rodriguez-Diaz et al. Cell Metabolism
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia
- (2018) Nina Xiaoyan Li et al. DIABETES
- Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial
- (2018) Jeremy Pettus et al. DIABETES OBESITY & METABOLISM
- Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids
- (2018) Nicolai J. Wewer Albrechtsen et al. DIABETOLOGIA
- Targeting the Incretin/Glucagon System with Triagonists to Treat Diabetes
- (2018) Megan E Capozzi et al. ENDOCRINE REVIEWS
- Incretin responses to oral glucose and mixed meal tests and changes in fasting glucose levels during 7 years of follow-up: The Hoorn Meal Study
- (2018) A. D. M. Koopman et al. PLoS One
- α-cell glucokinase suppresses glucose-regulated glucagon secretion
- (2018) Davide Basco et al. Nature Communications
- CPT1a-Dependent Long-Chain Fatty Acid Oxidation Contributes to Maintaining Glucagon Secretion from Pancreatic Islets
- (2018) Linford J.B. Briant et al. Cell Reports
- α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes
- (2018) Marcela Brissova et al. Cell Reports
- Hepatic Glucagon-Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents
- (2018) Teayoun Kim et al. DIABETES
- A novel dual glucagon-like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo-controlled first-in-human and first-in-patient trials
- (2018) Joachim Tillner et al. DIABETES OBESITY & METABOLISM
- Insulin Secretion Depends on Intra-islet Glucagon Signaling
- (2018) Berit Svendsen et al. Cell Reports
- Insulin and Glucagon: Partners for Life
- (2017) Jens Juul Holst et al. ENDOCRINOLOGY
- Stereoselective binding of agonists to the β2-adrenergic receptor: insights into molecular details and thermodynamics from molecular dynamics simulations
- (2017) Anita Plazinska et al. Molecular BioSystems
- The New Biology and Pharmacology of Glucagon
- (2017) T. D. Müller et al. PHYSIOLOGICAL REVIEWS
- Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition
- (2017) Haruka Okamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alpha TC1 and Beta-TC-6 genomic profiling uncovers both shared and distinct transcriptional regulatory features with their primary islet counterparts
- (2017) Nathan Lawlor et al. Scientific Reports
- Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
- (2017) Shuyang Traub et al. Cell Reports
- Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion
- (2017) H. Kristinsson et al. Scientific Reports
- Effects of 13-Hour Hyperglucagonemia on Energy Expenditure and Hepatic Glucose Production in Humans
- (2016) Manu Chakravarthy et al. DIABETES
- Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus
- (2016) Eric G. Vajda et al. DIABETES OBESITY & METABOLISM
- GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN
- (2016) Beth D. Mitchell et al. Endocrine Practice
- Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes
- (2016) Francesca Cinti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Searching for the physiological role of glucose-dependent insulinotropic polypeptide
- (2016) Jens Juul Holst et al. Journal of Diabetes Investigation
- Human Beta Cells Produce and Release Serotonin to Inhibit Glucagon Secretion from Alpha Cells
- (2016) Joana Almaça et al. Cell Reports
- Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist
- (2016) Nicolas Damond et al. eLife
- Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival
- (2016) Ursula H. Neumann et al. Molecular Metabolism
- Comprehensive alpha, beta and delta cell transcriptomes reveal that ghrelin selectively activates delta cells and promotes somatostatin release from pancreatic islets
- (2016) Michael R. DiGruccio et al. Molecular Metabolism
- Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia
- (2015) Thomas H. Meek et al. DIABETES
- Novel Observations From Next-Generation RNA Sequencing of Highly Purified Human Adult and Fetal Islet Cell Subsets
- (2015) David M. Blodgett et al. DIABETES
- Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
- (2015) Christof M. Kazda et al. DIABETES CARE
- Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
- (2015) V. Salem et al. DIABETES OBESITY & METABOLISM
- Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes
- (2015) Vivi R. Steenberg et al. DIABETOLOGIA
- Glucagon Cell Hyperplasia and Neoplasia With and Without Glucagon Receptor Mutations
- (2015) Bence Sipos et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure
- (2015) Jonatan Ising Bagger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion
- (2015) Talitha van der Meulen et al. NATURE MEDICINE
- Islet α cells and glucagon—critical regulators of energy homeostasis
- (2015) Jonathan E. Campbell et al. Nature Reviews Endocrinology
- Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway
- (2015) May-Yun Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic β-cells via protein kinase A
- (2015) Sindhu Rajan et al. Molecular Metabolism
- Control of Insulin Secretion by Cholinergic Signaling in the Human Pancreatic Islet
- (2014) J. Molina et al. DIABETES
- Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes
- (2014) Mikkel Christensen et al. DIABETES
- Absence of Glucagon and Insulin Action Reveals a Role for the GLP-1 Receptor in Endogenous Glucose Production
- (2014) Lucy S. Jun et al. DIABETES
- Glucagon responses to increasing oral loads of glucose and corresponding isoglycaemic intravenous glucose infusions in patients with type 2 diabetes and healthy individuals
- (2014) Jonatan I. Bagger et al. DIABETOLOGIA
- Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice
- (2014) Arthur T. Suckow et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transgene-induced pleiotropic effects in transplastomic plants
- (2013) N. Scotti et al. BIOTECHNOLOGY LETTERS
- Role of KATP Channels in Glucose-Regulated Glucagon Secretion and Impaired Counterregulation in Type 2 Diabetes
- (2013) Quan Zhang et al. Cell Metabolism
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
- (2013) Negar Karimian et al. DIABETES
- Amelioration of Hypoglycemia Via Somatostatin Receptor Type 2 Antagonism in Recurrently Hypoglycemic Diabetic Rats
- (2013) J. T. Y. Yue et al. DIABETES
- Identification and Characterization of GLP-1 Receptor-Expressing Cells Using a New Transgenic Mouse Model
- (2013) P. Richards et al. DIABETES
- Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala
- (2013) J A Parker et al. INTERNATIONAL JOURNAL OF OBESITY
- SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells
- (2012) Balrik Kailey et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
- (2012) Chutima Talchai et al. CELL
- Clinical Diabetes/Therapeutics
- (2012) DIABETES
- Liver-Specific Disruption of the Murine Glucagon Receptor Produces -Cell Hyperplasia: Evidence for a Circulating -Cell Growth Factor
- (2012) C. Longuet et al. DIABETES
- Minireview: The Role of the Autonomic Nervous System in Mediating the Glucagon Response to Hypoglycemia
- (2012) Gerald J. Taborsky et al. ENDOCRINOLOGY
- Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by γ-Hydroxybutyrate and Glycine
- (2012) Changhong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
- (2012) Roger H. Unger et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic manifestations of insulin deficiency do not occur without glucagon action
- (2012) Y. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Islets Have a Lot of Nerve! Or Do They?
- (2011) Gerald J. Taborsky Cell Metabolism
- Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour
- (2011) Roy Eldor et al. CLINICAL ENDOCRINOLOGY
- Orals
- (2011) DIABETES
- Remodeling of Hepatic Metabolism and Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides
- (2011) C. Watanabe et al. DIABETES
- Glucose-Dependent Insulinotropic Polypeptide: A Bifunctional Glucose-Dependent Regulator of Glucagon and Insulin Secretion in Humans
- (2011) M. Christensen et al. DIABETES
- Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
- (2011) Y. Lee et al. DIABETES
- Early milestones in glucagon research
- (2011) P. J. Lefèbvre DIABETES OBESITY & METABOLISM
- Physiologic action of glucagon on liver glucose metabolism
- (2011) C. J. Ramnanan et al. DIABETES OBESITY & METABOLISM
- Brain glucose sensing and neural regulation of insulin and glucagon secretion
- (2011) B. Thorens DIABETES OBESITY & METABOLISM
- Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice
- (2011) J. Mu et al. DIABETOLOGIA
- Incretin Hormone and Insulin Responses to OralVersusIntravenous Lipid Administration in Humans
- (2011) Ola Lindgren et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis
- (2011) Safina Ali et al. JOURNAL OF CLINICAL INVESTIGATION
- Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor
- (2010) Wei Gu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucose Suppression of Glucagon Secretion
- (2010) Sylvain J. Le Marchand et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
- (2009) Dan Kawamori et al. Cell Metabolism
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
- (2009) Christopher B. Newgard et al. Cell Metabolism
- Exogenous Glucose-Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes
- (2009) C. W. Chia et al. DIABETES
- Insulin Storage and Glucose Homeostasis in Mice Null for the Granule Zinc Transporter ZnT8 and Studies of the Type 2 Diabetes-Associated Variants
- (2009) T. J. Nicolson et al. DIABETES
- Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell Tumor
- (2009) Cuiqi Zhou et al. PANCREAS
- The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting
- (2008) Christine Longuet et al. Cell Metabolism
- The Barrier of Hypoglycemia in Diabetes
- (2008) P. E. Cryer DIABETES
- The Role of Incretins in Glucose Homeostasis and Diabetes Treatment
- (2008) W. Kim et al. PHARMACOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More